Company Overview
Snapshot
Founded in September 2009 by Dror Robinson, Bonfix operates with 1–10 employees. The company is developing a novel shock-absorbing fixation system for medical applications. In March 2023, Bonfix secured seed funding from Docor International Management.
Business overview
Bonfix is a Health Tech & Life Sciences company focused on developing medical devices. The company's core technology involves a minimally invasive device designed for the correction of hallux valgus, commonly known as bunions. This innovative approach aims to replace traditional osteotomies with an ambulatory surgical procedure that minimizes functional limitations for patients. Bonfix operates within the Medical Devices, Medical Treatment & Therapeutics sectors, targeting healthcare providers.
Log in to access full profile ›Company Intelligence Q&A
- What is Bonfix's primary focus in the medical device sector?
- Bonfix is developing a minimally invasive device for the correction of hallux valgus, aiming to provide an alternative to traditional surgical procedures involving osteotomies and bone fragment manipulation.
- When was Bonfix founded and by whom?
- Bonfix was founded in September 2009 by Dror Robinson.
- What was a significant technology development by Bonfix?
- In September 2009, Bonfix developed a novel shock-absorbing fixation system, applicable in medical devices, minimally invasive surgery, bone, and orthopedics.
- What is the current product stage of Bonfix's technology?
- Bonfix's product is currently in the clinical trial stage, as of its last update in July 2023.
- Which investor participated in Bonfix's seed funding round?
- In March 2023, Bonfix received seed funding from Docor International Management.